Merck KGaA (OTCMKTS:MKKGY – Get Free Report) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 16,700 shares, a growth of 4,075.0% from the December 15th total of 400 shares. Based on an average daily volume of 329,400 shares, the days-to-cover ratio is currently 0.1 days.
Merck KGaA Trading Down 1.1 %
Shares of OTCMKTS MKKGY traded down $0.33 during trading hours on Monday, hitting $29.22. The company’s stock had a trading volume of 93,074 shares, compared to its average volume of 152,879. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.91 and a current ratio of 1.33. The stock has a market cap of $18.88 billion, a price-to-earnings ratio of 18.04, a P/E/G ratio of 2.32 and a beta of 0.93. Merck KGaA has a 12 month low of $28.29 and a 12 month high of $39.17. The business has a 50-day simple moving average of $29.93 and a 200-day simple moving average of $33.39.
Wall Street Analysts Forecast Growth
Separately, The Goldman Sachs Group assumed coverage on Merck KGaA in a research note on Thursday, September 19th. They issued a “buy” rating on the stock.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Recommended Stories
- Five stocks we like better than Merck KGaA
- What Are Some of the Best Large-Cap Stocks to Buy?
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Options Trading – Understanding Strike Price
- Delta Can Fly to New Highs in 2025; Here’s Why
- How to Most Effectively Use the MarketBeat Earnings Screener
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.